Evidence map›Paper›PMID 16181799›Full record

ArticleThe international journal of biochemistry & cell biology2006

Hyaluronan fragments activate nitric oxide synthase and the production of nitric oxide by articular chondrocytes.

Stanca Iacob, Cheryl B Knudson

Open access · greenAbstract read
In one paragraph

Article in The international journal of biochemistry & cell biology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 54 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. The pericellular hyaluronan of articular chondrocytes.Matrix biology : journal of the International Society for Matrix Biology · 2019
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Joint aging and chondrocyte cell death.International journal of clinical rheumatology · 2010
    Article
  17. Article
  18. Article
  19. Hyaluronan promotes the chondrocyte response to BMP-7.Osteoarthritis and cartilage · 2009
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Stanca IacobDepartment of Biochemistry, Rush University Medical Center, 1653 West Congress Parkway, Cohn 516, Chicago, IL 60612, USA.
Cheryl B Knudson
Rush University Medical Center · US

Funding

SPECIALIZED CENTER OF RESEARCH IN OSTEOARTHRITISP50AR039239 · NIAMS · RUSH UNIVERSITY MEDICAL CENTER · PI OEGEMA, THEODORE RICHARD · 1987 to 2007
$8.5M
HYALURONAN-CELL INTERACTIONS IN CARTILAGER01AR039507 · NIAMS · RUSH UNIVERSITY MEDICAL CENTER · PI KNUDSON, CHERYL B · 1998 to 2013
$3.1M
TRAINING IN CARTILAGE RESEARCHT32AR007590 · NIAMS · RUSH UNIVERSITY MEDICAL CENTER · PI OEGEMA, THEODORE RICHARD · 1996 to 2010
$2.8M
NIAMS NIH HHS P50 AR039239NIAMS NIH HHS P50-AR39239NIAMS NIH HHS R01 AR039507NIAMS NIH HHS R01-AR39507NIAMS NIH HHS T32 AR007590NIAMS NIH HHS T32-AR0759
6 · The paper itself

Abstract

Chondrocyte CD44 receptors anchor hyaluronan to the cell surface, enabling the assembly and retention of proteoglycan aggregates in the pericellular matrix. Hyaluronan-CD44 interactions also provide signaling important for maintaining cartilage homeostasis. Disruption of chondrocyte-hyaluronan contact alters CD44 occupancy, initiating alternative signaling cascades. Treatment with hyaluronan oligosaccharides is one approach to uncouple CD44 receptors from its native ligand, hyaluronan. In bovine articular chondrocytes, treatment with hyaluronan oligosaccharides or purified hyaluronan hexasaccharides induced the production of nitric oxide that mirrored nitric oxide production following interleukin-1 treatment. In contrast, 120 and 1,260 kDa hyaluronan did not induce production of nitric oxide. Human chondrocytes responded similarly to treatment with hyaluronan or hyaluronan oligosaccharides. Nitric oxide production from chondrocytes was mediated by activation of the inducible nitric oxide synthase, as confirmed by mRNA expression and inhibition of nitric oxide production by diphenyleneiodonium. Co-treatment of chondrocytes with hyaluronan oligosaccharides and interleukin-1 did not demonstrate additive effects. Blocking interleukin-1 receptors with an antagonist did not abolish the production of nitric oxide induced by treatment with hyaluronan oligosaccharides. Moreover, only COS-7 following transfection with a pCD44, not the CD44-null parental cells, responded to treatment with hyaluronan oligosaccharides by releasing nitric oxide. This study demonstrates a novel signaling potential by hyaluronan fragments, in lieu of endogenous hyaluronan-chondrocyte interactions, resulting in the activation of inducible nitric oxide synthase.

Indexed as

AnimalsCartilage, ArticularCattleChlorocebus aethiopsChondrocytesCOS CellsEnzyme ActivationEnzyme InhibitorsGene Expression Regulation, EnzymologicHumansHyaluronan ReceptorsHyaluronic AcidNitric OxideNitric Oxide Synthase Type IIOligosaccharidesOnium CompoundsdiphenyleneiodoniumEnzyme InhibitorsHyaluronan ReceptorsHyaluronic AcidNitric OxideNitric Oxide Synthase Type IIOligosaccharidesOnium Compounds

Identifiers

PMID16181799
PMCPMC3139231
OpenAlexW2085489410

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.